CLODERM Trademark
Trademark Overview
On Thursday, July 27, 1972, a trademark application was filed for CLODERM with the United States Patent and Trademark Office. The USPTO has given the CLODERM trademark a serial number of 72431021. The federal status of this trademark filing is EXPIRED as of Monday, August 8, 1994. This trademark is owned by KNOLL PHARMACEUTICAL COMPANY. The CLODERM trademark is filed in the Pharmaceutical Products category with the following description:
PHARMACEUTICAL PREPARATION, IN CREAM AND/OR OINTMENT FORM, FOR THE TREATMENT OF INFLAMMATORY DERMATOSES
General Information
| Serial Number | 72431021 |
| Word Mark | CLODERM |
| Filing Date | Thursday, July 27, 1972 |
| Status | 900 - EXPIRED |
| Status Date | Monday, August 8, 1994 |
| Registration Number | 0971766 |
| Registration Date | Tuesday, October 30, 1973 |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | PHARMACEUTICAL PREPARATION, IN CREAM AND/OR OINTMENT FORM, FOR THE TREATMENT OF INFLAMMATORY DERMATOSES |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 018 |
| Class Status Code | 9 - Expired |
| Class Status Date | Monday, August 8, 1994 |
| Primary Code | 018 |
| First Use Anywhere Date | Monday, July 24, 1972 |
| First Use In Commerce Date | Monday, July 24, 1972 |
Trademark Owner History
| Party Name | KNOLL PHARMACEUTICAL COMPANY |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | ORANGE, NJ 07051 |
Trademark Events
| Event Date | Event Description |
| Monday, August 8, 1994 | EXPIRED SEC. 9 |
| Monday, August 6, 1979 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
